Abstract
Commercial and military aircrew operate within a multi-hazard auditory environment that combines cabin acoustic noise, chronic hypobaric hypoxia under regulatory cabin-pressure caps, and altitude-dependent cosmic ionizing radiation. Their convergent action on cochlear vulnerability has not been quantified, and no decision framework exists for matching threshold sound conditioning (TSC) target frequencies to operational flight profiles. This work is a computational, hypothesis-generating framework rather than an empirical study. We propose that the dominant frequency band of cochlear vulnerability in aircrew (3–6 kHz) emerges as the geometric overlap of three mechanism-distinct vulnerability kernels and coincides with the TSC selection region (3, 4 or 6 kHz) evaluated in the Kwak and Kwak 2020 randomized controlled trial. We construct a Cumulative Cochlear Stress Index (CCSI) that combines a CARI-7-derived radiation dose formula, an estimated-alveolar-tension hypoxia term and an A-weighted noise term, weighted by frequency-resolved Gaussian vulnerability kernels in log-octave space. The geometric mean of the three kernels peaks at f* = 4.23 kHz (FWHM 2.06–8.72 kHz) and is consistent with the convergence hypothesis on the discrete clinical TSC grid (argmax 4 kHz). A sensitivity analysis over the full audiometric grid {0.5, 1, 2, 3, 4, 6, 8, 12} kHz, six mixing-weight scenarios (including a radiation-excluded wR = 0 case) and four aircrew profiles finds the global CCSI argmax inside 3/4/6 kHz in all 24 combinations, and a Monte-Carlo randomization of the kernel parameters within literature bounds reproduces the 4 kHz convergence in 99.2% of draws, vs. 23.1% for unconstrained kernels, a non-tautological robustness check. Acoustic noise and hypobaric hypoxia are treated as the primary, mechanistically supported axes, while cosmic ionizing radiation is retained as an exploratory third axis given the absence of direct cochlear evidence at cruise-altitude doses. A machine-learning identifiability check (Random Forest, Gradient Boosting and Ridge ensembles on a 500-profile synthetic dataset; band-averaged R2≈0.98) is reported as an internal model-recovery check rather than a biological validation. The framework supports prospective evaluation of TSC in aircrew cohorts.
Keywords: aircrew, cochlear vulnerability, cosmic radiation, hypobaric hypoxia, machine-learning, sensorineural hearing loss, threshold sound conditioning
1. Introduction
1.1. Aircrew as a cochlear-risk population
Pilots and cabin attendants represent one of the longest-studied occupational populations with documented sensorineural hearing loss (SNHL). A cross-sectional audiometric study of n = 3, 130 Brazilian civilian pilots found a noise-induced hearing loss prevalence of 18.9% at 4 kHz, 15.8% at 6 kHz and 9.5% at 3 kHz, with the classical noise-notch pattern centered near 4 kHz (1). The same pattern is reproduced in fighter-pilot cohorts using extended high-frequency audiometry, where significant threshold elevation in the 4–8 kHz band emerges relative to age-matched controls (2), in Swedish commercial pilot and cabin-crew surveys (3, 4), in helicopter pilots vs. air-traffic controllers (5) and in larger Saudi military cohorts (6). After-flight temporary threshold shifts are recoverable but cumulative; extended high-frequency audiometry detects the earliest audiometric signal of damage before conventional pure-tone audiometry becomes positive (7, 8). Cabin acoustic measurements compiled by the U.S. Government Accountability Office report cabin LAeq values of 74–84 dBA, cockpit values of 75–81 dBA, and military/fighter cockpit values reaching 85–95 dBA (9).
1.2. Beyond noise: a multi-hazard cochlear environment
What is less appreciated in audiology is that aircrew do not operate under noise alone. At cruise altitude they sustain two additional physiologically relevant cochlear stressors that operate continuously over each flight segment: chronic hypobaric hypoxia under the regulatory cabin-pressure schedule, and a level of cosmic ionizing radiation that rises exponentially with altitude through the residual atmosphere. Although each of these has been studied in isolation, their convergent action on the cochlea has not been treated quantitatively in the audiology literature.
1.3. Hypobaric hypoxia and the cochlea
Federal aviation regulation 14 CFR 25.841 caps the cabin altitude during cruise at ≈ 2.44 km (8,000 ft equivalent), but this still drives the estimated alveolar oxygen tension PAO2 from ≈ 99 mmHg at sea level to ≈ 55 mmHg at the cap (a ≈ 45% reduction under the simplified West alveolar gas equation; see Equation 6). Arterial PaO2 is somewhat lower than PAO2 due to the A–a gradient, and we use PAO2 throughout as a proxy for arterial oxygen availability. This reduced alveolar tension is sustained for the duration of the flight segment. The ADEMED 2011 high-altitude expedition demonstrated in volunteers acclimatized over 10 days at 5,300 m that the same noise dose produces a substantially larger temporary threshold shift under hypobaric hypoxia than at sea level, and that acclimatization does not protect the inner ear despite raising arterial oxygen saturation (10). A parallel 1-year cohort of soldiers permanently stationed at high altitude reported persistent threshold elevation centered at 2–4 kHz (11), and a rat auditory-brainstem-response model demonstrated synergistic noise–hypoxia susceptibility of the cochlea (12). Aviation otology additionally recognizes middle-ear barotrauma at descent as a peripheral mechanism that compounds inner-ear stress in the same flight segment (13–17).
1.4. Cosmic ionizing radiation, with limited cochlear evidence
Aircrew are classified as an occupationally exposed population under ICRP Publication 103 (18), and large multi-national epidemiological cohorts confirm elevated incidence of specific malignancies that co-vary with cumulative cosmic-radiation dose (19–22), with cosmic ionizing radiation increasingly characterized as a DNA-damaging agent in flight crews (23). The galactic cosmic-ray flux at cruise altitude is modeled by the U.S. FAA CARI-7 dose model (24) and the European NAIRAS framework (25, 26), and in-flight Liulin spectrometry over the Korean peninsula at FL300 (9, 144 m) reports ambient dose-equivalent rates of 2.3 ± 0.17μSv h−1 (27). A simple exponential altitude–dose approximation to CARI-7 outputs under Solar Cycle 25 maximum conditions (used here as a screening-level dose proxy; see Section 2.4 and Equations 1, 5) implies annualized effective doses at ~ 40,000 ft routinely exceed the ICRP public reference level of 1 mSv yr−1 and reach 1.7–2.2 mSv yr−1 on polar routes.
A direct, dose-matched epidemiological link between the cruise-altitude cosmic-radiation environment and human cochlear dysfunction is not currently available. The only mechanistic evidence comes from clinical head-and-neck radiotherapy at far higher cochlear doses (35–70 Gy): a dose-response transition near 35–45 Gy (28), a high-frequency-biased prevalence pattern (29), and ribbon-synapse disruption (30), which we review quantitatively in Section 2.5 rather than repeat here. We therefore treat ionizing radiation as a candidate, frequency-resolved contributor rather than an established aviation auditory hazard.
1.5. A convergent 3–6 kHz vulnerability band
The three pathways above place their cochlear emphasis on overlapping, but not identical, frequency bands. The classical noise-notch peaks near 4 kHz with shoulders at 3 and 6 kHz (1). The hypoxia-conditioned threshold-shift band peaks at 2–4 kHz (10, 11), shifted toward lower-mid frequencies relative to pure noise. The radiation-cochlea band is high-frequency-biased and peaks at 6–8 kHz, reflecting basal ribbon-synapse vulnerability (29, 30). The geometric overlap of these three bands defines a 3–6 kHz region that is the central concern of the present paper.
1.6. Threshold sound conditioning as a frequency-selective therapeutic paradigm
Within otology, threshold sound conditioning (TSC) has been clinically evaluated in a randomized controlled trial as a paradigm for inducing adult auditory pathway plasticity. The principle draws on the seminal Noreña and Eggermont demonstration that an enriched acoustic environment at frequencies matched to the deprived cochlear region prevents post-trauma reorganization of the primary auditory cortex tonotopic map (31–34). Kwak & Kwak operationalized this principle into a clinical protocol that delivers a sub-threshold tone, individualized to the patient's worst-threshold frequency among 3, 4, or 6 kHz, for 1 h per day over two to 3 weeks via a behind-the-ear hearing-aid platform. In a Stanford-IRB-approved double-blind randomized controlled trial of 39 evaluable subjects, the TSC arm achieved threshold amelioration in 78% of participants vs. 44% in the control arm [p = 0.008 (35–37)]. The protocol's empirical choice of 3, 4 or 6 kHz as the candidate conditioning band is exactly the convergence region identified above.
1.7. Knowledge gap and contributions
What remains absent from the literature is a quantitative framework that connects the multi-hazard operational environment of aircrew to the frequency-resolved TSC target. The clinical TSC protocol selects the conditioning frequency from the patient's worst pure-tone threshold, but in a preventive aviation-medicine context, where audiometric loss has not yet developed but cumulative exposure already has, the prioritization must instead be derived from the flight profile itself (i.e., a priori, before any audiogram is available).
The present study advances four contributions.
We synthesize the available aviation-medicine, hypoxic-cochlea, ionizing-radiation and TSC literature into an explicit 3–6 kHz convergence hypothesis, identifying the frequency band at which cabin-noise and hypobaric-hypoxia vulnerability co-localize on the cochlea, with cosmic ionizing radiation considered as an exploratory high-frequency-biased third axis rather than an established hazard (Sections 2–4).
We introduce the Cumulative Cochlear Stress Index (CCSI), a physics- and audiology-informed predictive model that takes flight altitude, geomagnetic cut-off rigidity, heliocentric potential, flight-hours and cabin acoustic level as inputs and returns a frequency-resolved vulnerability score across eight standard audiometric bands (Section 5). The radiation component of CCSI is anchored to a screening-level approximation to the CARI-7 dose model (24) and is benchmarked against published in-flight aircrew dosimetry (27, 38, 39), and the frequency kernels are calibrated from published audiometric and mechanistic data.
We provide a machine-learning identifiability check [Random Forest (40), Gradient Boosting (41) and Ridge ensembles, implemented in scikit-learn (42), on a 500-profile synthetic dataset] confirming that each operational input activates the frequency bands predicted by its underlying physiology. Because the regression labels are themselves CCSI values, this is an internal model-recovery check, not a biological validation, and is reported in full in Supplementary material.
We apply the framework to four representative aircrew operational profiles (polar long-haul, mid-latitude long-haul, domestic short-haul, and military fighter/rotary) and report the recommended TSC target frequency within the clinical 3/4/6 kHz set defined by the Kwak & Kwak trial (Section 6).
The framework is intended as a transparent decision-support tool that supports prospective evaluation of frequency-targeted TSC in aircrew cohorts, in advance of the audiometric data required to test the hypothesis directly.
2. Multi-hazard auditory environment at cruise altitude
This section consolidates the quantitative characteristics of the three principal cochlear stressors acting simultaneously during commercial and military flight operations, and the limited but mechanistically suggestive evidence linking cruise-altitude cosmic radiation to cochlear damage. The combined picture is summarized in Figure 1.
Figure 1.

Multi-hazard auditory environment of cruise-altitude operations. (A) Effective dose rate of galactic cosmic radiation vs. cruise altitude under Solar Cycle 25 maximum conditions, parameterized by geomagnetic cut-off rigidity Rc. Square marker: Lee et al. (27) in-flight Liulin measurement at FL300 over the Korean peninsula (converted from H*(10) to effective dose). (B) Cabin acoustic environment (LAeq) vs. cruise altitude from a synthetic (n = 500) dataset, with NIOSH REL 85 dBA and OSHA PEL 90 dBA reference levels. (C) Hypobaric hypoxia index 1−PAO2(h)/PAO2(0) alveolar oxygen tension under the simplified West alveolar gas equation; see Equation (6), contrasting unpressurized exposure with the FAA 14 CFR 25.841 pressurization cap (cabin altitude bounded at ≈2.44 km).
2.1. Cabin and cockpit acoustic environment
The acoustic level inside a commercial aircraft cabin during cruise is determined by engine and aerodynamic noise transmitted through the fuselage. Compiled measurements summarized by the U.S. Government Accountability Office report cabin LAeq values of 74–84 dBA on typical wide-body and narrow-body cruise segments, cockpit values of 75–81 dBA, and military or fighter cockpit values reaching 85–95 dBA, with peak A-weighted excursions during cabin-call signals and turbulence reaching 105 dBA (9). In our synthetic dataset (Figure 1B; n = 500 uniformly sampled profiles between 3 and 12 km), the implied cabin LAeq trends modestly upward with cruise altitude, reflecting both higher engine thrust and the lower density-driven aerodynamic excitation of the fuselage.
Although these LAeq values mostly remain below the OSHA permissible exposure limit of 90 dBA for an 8-h reference shift and only marginally exceed the more conservative NIOSH recommended exposure limit of 85 dBA, two operational features of aviation are not adequately captured by the standard time-weighted average. First, cumulative exposure for long-haul wide-body aircrew, who routinely log 600–900 flight-hours per year, integrates to a substantially higher annualized dose than the single-shift OSHA reference assumes. Second, the frequency content of cabin and cockpit noise is concentrated in the 0.5–4 kHz band, overlapping the cochlear regions of highest mechanical vulnerability and producing the classical 4 kHz noise-notch documented in the Brazilian (n = 3, 130; Figure 2A) (1) and military (2–6) cohorts cited in Section 1.
Figure 2.

Convergent 3–6 kHz cochlear vulnerability across noise, radiation and hypoxia pathways. (A) Aircrew NIHL prevalence per audiometric band from Falcão et al. 2014 (n = 3, 130 civilian pilots) (1). (B) Radiotherapy-induced SNHL prevalence per audiometric band for cochlear doses >45 Gy (28, 29). (C) Normalized vulnerability kernels for noise (Gaussian peak 4 kHz), radiation (peak 6 kHz) and hypoxia (peak 3 kHz) in log-octave frequency space, with the geometric-mean convergence curve and the clinical TSC region [3, 4 or 6 kHz; (35)].
2.2. Hypobaric hypoxia under regulatory cabin pressurization
Federal aviation regulation 14 CFR 25.841 mandates that the cabin altitude be maintained at or below ≈ 2.44 km (8,000 ft equivalent) during cruise. Applying a simplified alveolar gas equation under standard barometric assumptions ( mmHg, FiO2 = 0.2095, PaCO2 = 40 mmHg, RQ = 0.8) yields an estimated alveolar oxygen tension PAO2 that falls from ≈ 99 mmHg at sea level to ≈ 55 mmHg at the regulatory cap, a ≈ 45% reduction. The strict alveolar gas equation returns PAO2, not arterial PaO2; the two differ by an A–a gradient that depends on ventilation–perfusion matching and individual physiology, and we therefore use PAO2 as a proxy for arterial oxygen availability throughout. The implied alveolar hypoxia index H(h) = 1−PAO2(h)/PAO2(0) is plotted in Figure 1C; pressurization flattens what would otherwise be a monotonically rising exposure into a plateau, but the plateau itself is non-negligible and is sustained for the entire cruise segment.
The biological relevance of this residual hypoxia for the cochlea is established by the ADEMED 2011 high-altitude expedition. After 10 days of acclimatization at 5,300 m (Gorak Shep, Solo Khumbu, Nepal), the same 90 dB white-noise exposure produced a substantially larger temporary threshold shift than at low altitude; critically, acclimatization did not protect the inner ear, although it did raise arterial oxygen saturation (10). The mechanism, supported by complementary auditory-brainstem-response work in rats (12), is thought to reflect oxygen-supply limitations at the stria vascularis under the combined demand of acoustic stimulation, with insufficient mitochondrial support of the active hair-cell amplifier in basal-cochlear regions. A 1-year longitudinal cohort of soldiers permanently stationed at high altitude reported persistent threshold elevation centered at 2–4 kHz (11), the frequency band that geometrically overlaps with the noise-notch peak.
2.3. Otitic barotrauma at descent
Cabin pressurization also exposes the middle ear to repeated pressure gradients during descent, with implications that are peripheral but not negligible for inner-ear stress. Otic barotrauma during air travel arises from inadequate equalization between middle-ear and external atmospheric pressure across the Eustachian tube (13, 15–17). Point-prevalence studies of post-flight barotitis in mixed adult and pediatric populations report incidence of 10–20%, with effective mitigation by autoinflation maneuvers (14). While the cochlear consequences are mediated indirectly, through pressure-driven round-window membrane displacement and rare perilymphatic fistula, the additive contribution of barotrauma to overall in-flight cochlear stress justifies its inclusion as an auxiliary environmental factor in this section.
2.4. Cosmic ionizing radiation dose climatology
Cosmic radiation dose rate at flight altitude is the joint product of the galactic cosmic-ray flux (modulated by solar activity through the heliocentric potential, HCP), the geomagnetic cut-off rigidity Rc (set by the geographic location of the route), and the residual atmospheric overburden (determined by cruise altitude). The U.S. FAA CARI-7 model (24) and the European NAIRAS framework (25, 26) are the standard physics-based tools for computing the effective dose rate D(h, Rc, HCP). Building on these, we use in this work a screening-level closed-form exponential approximation to the CARI-7 altitude–dose relation under Solar Cycle 25 maximum conditions,
| (1) |
with extensions for geomagnetic latitude correction flat(Rc) and solar modulation f⊙(HCP) that we adopt in Section 5. Equation 1 is a screening-level closed-form approximation to the CARI-7 altitude–dose relation and is benchmarked against the Korean-peninsula in-flight Liulin spectrometer measurements of Lee et al. (2.3 ± 0.17μSv h−1 at FL300) (27), shown as the anchor marker in Figure 1A; the predicted dose magnitudes are consistent with broader published aircrew dose climatologies and model intercomparisons (38, 39, 43, 44). Three representative cut-off rigidities are plotted: polar (Rc = 1.0 GV, characteristic of Svalbard and northern Canadian routes), mid-latitude Korea (Rc = 9.96 GV; reference for the present framework), and equatorial (Rc = 17.0 GV; Singapore/Nairobi class).
Two operationally relevant features emerge from this dose climatology. First, the exponential altitude dependence produces a 24.7 × range in dose rate between 10,000 ft and 40,000 ft, making cruise altitude the dominant determinant of cumulative dose. Second, polar routes systematically exceed 1 mSv yr−1 at FL300 even at moderate annual flight-hours, while equatorial routes can remain comfortably below the ICRP public reference level even at high-altitude cruise; the operational implication is that the geographic signature of the route is as important as its altitude profile for radiation-component prioritization.
2.4.1. Quantification and validation of the radiation factor
The radiation exposure is quantified entirely from operational inputs derivable from flight-log metadata (cruise altitude, route-derived geomagnetic cut-off rigidity Rc, solar-cycle phase (HCP) and segment flight-hours) through the closed-form CARI-7 approximation of Equations 1–5; no per-flight dose reconstruction or new measurement is required. The dose side is validated against published in-flight dosimetry: the Lee et al. Liulin measurement at FL300 (27) and broader model intercomparisons and compiled datasets (38, 39, 43, 44). The cochlear-effect side, whether this chronic low-dose exposure damages the cochlea, cannot yet be validated, because no audiometric or cochlear endpoint has been reported at μSv–mSv doses (Section 2.5); the appropriate data-collection routes are (i) a prospective aircrew audiometric cohort stratified by cumulative dose (Section 6) and (ii) accelerator-based galactic-cosmic-ray analog studies in animal models with auditory endpoints. Until such data exist the radiation axis is retained as exploratory, and the radiation-excluded (wR = 0) scenario of Section 5.5 confirms that the conclusions do not depend on it.
2.5. Limited evidence linking cruise-altitude radiation to cochlear damage
Direct epidemiological evidence linking the cruise-altitude cosmic-radiation environment to human cochlear dysfunction is not currently available, and we say so explicitly. The aircrew cohorts of Pukkala et al., Hammer et al., and Langner et al. were designed to detect cancer endpoints rather than audiometric ones, and to our knowledge no aircrew study has reported pure-tone audiometry stratified by cumulative cosmic-radiation dose (19–22). What is available is a mechanism-level corpus drawn from clinical head-and-neck radiotherapy at much higher delivered cochlear doses. We are not aware of any study reporting auditory or cochlear endpoints from chronic low-dose (μSv–mSv) ionizing radiation; the accelerator-based galactic-cosmic-ray simulation studies (45, 46) report central-nervous-system rather than specifically cochlear outcomes. This low-dose cochlear data gap is one the present framework flags explicitly rather than fills.
2.5.1. Dose-response evidence at therapeutic levels
The QUANTEC review of Bhandare et al. identified a clinically relevant transition near 35–45 Gy to the cochlea, above which sensorineural hearing loss prevalence rises steeply (28), and the systematic review of Theunissen et al. across 53 head-and-neck cohorts quantified the high-frequency-biased prevalence pattern reproduced in Figure 2B, with SNHL rising from 22% at 2 kHz to 67% at 8 kHz (29, 47, 48).
2.5.2. Mechanism at the ribbon synapse
The 2022 study of Liu et al. (30) provided the first direct mechanistic demonstration that head-and-neck radiotherapy specifically disrupts cochlear ribbon synapses in C57BL/6J mice exposed to 10 and 20 Gy of 60Co radiation, with a high-frequency basal cochlear bias. The disruption was localized at the inner hair-cell–auditory-nerve interface and was quantified by anti-RIBEYE/CtBP2 immunolabeling. Complementary cellular work implicates reactive-oxygen-species pathways, mitogen-activated protein kinase signaling, and p53-mediated apoptosis as the intracellular cascade linking radiation-induced damage to cochlear hair-cell death and synapse loss (48, 49).
2.5.3. Scope of the radiation hypothesis in the present work
Because the dose magnitude at cruise altitude is several orders of magnitude below the radiotherapy range that produces measurable clinical SNHL, we are explicit that the present paper does not claim cosmic radiation as an established aviation auditory hazard. We treat it as a candidate contributor whose frequency signature, if mechanistically active even at low chronic doses, would be high-frequency-biased and would co-localize with the classical noise-notch in the 3–6 kHz convergence band that the remainder of this paper formalizes. This positioning is consistent with the limited-evidence framing established in Section 1 and is preserved in the CCSI weighting choices reported in Section 5.
Together, Sections 2.1–2.5 establish that the aircrew cochlea is exposed to three temporally co-occurring stressors, each with documented or mechanistically plausible frequency-band signatures concentrated within 3–6 kHz. The quantitative integration of these three streams, and the resulting TSC-region prioritization across operational profiles, is the subject of Sections 4–6.
3. Threshold sound conditioning: current evidence
3.1. Mechanism of action: auditory pathway plasticity in adults
The mechanistic basis of threshold sound conditioning rests on a substantial body of work demonstrating that the adult mammalian auditory pathway retains an unexpectedly broad capacity for experience-dependent reorganization. Recanzone et al. first showed in adult owl monkeys that perceptual discrimination training induces measurable enlargement of the cortical representation of the trained frequency band in primary auditory cortex (33), establishing that tonotopic maps are not fixed at developmental closure. Twelve years later, Noreña and Eggermont demonstrated in a noise-trauma cat model that exposure to an enriched acoustic environment composed of tone-pips spanning the deprived frequency region during the post-trauma window both reduces permanent threshold shift and prevents the tonotopic-map reorganization that normally accompanies acoustic deprivation (31); the same group subsequently showed that this paradigm abolishes neural signatures of tinnitus (32). More recent reviews have framed these findings as defining a clinically actionable plasticity window in which targeted acoustic exposure can recruit residual cochlear function and stabilize central representations (34). The cochlear-synaptopathy literature has additionally established that the auditory nerve degenerates selectively after even temporary threshold shifts of seemingly modest magnitude, providing a second rationale for early intervention targeted at preserving the residual ribbon-synapse pool (50–53).
3.2. Clinical RCT evidence: the Kwak and Kwak 2020 trial
The clinical translation of these findings into a deployable intervention is captured in the Kwak & Kwak randomized controlled trial, conducted under Stanford University Medical Center IRB oversight and reported initially as an American Academy of Neurology abstract (36) and subsequently in extenso in Laryngoscope Investigative Otolaryngology (35). Ninety-six candidates were screened from a single tertiary-care neurology clinic; following application of audiometric and protocol-compliance criteria, 42 participants were randomized and 39 completed the study (23 TSC, 16 control). Inclusion required at least one pure-tone frequency threshold above 40 dB HL; exclusion criteria included three or more air-bone gaps exceeding 10–15 dB or three or more frequency regions with profound loss above 90 dB.
Pure-tone audiometry was performed at 0.25, 0.5, 1, 2, 3, 4, 6, 8, and 12 kHz before and after intervention. The TSC arm received a single tonal stimulus, individually selected at 3, 4 or 6 kHz to match the participant's poorest pure-tone threshold, delivered for 1 h per day via a behind-the-ear digital hearing aid for two to 3 weeks. The control arm received an identical hearing-aid platform without the TSC waveform. The primary endpoint was threshold amelioration defined under two dependent-variable formulations (DV1 and DV2) over the analyzed frequency set. Threshold amelioration was observed in 78% of the TSC arm vs. 44% in the control arm, with statistical separation by Scheffé post-hoc testing (p = 0.008091 in DV1, p = 0.000546 in DV2). A sub-group analysis showed that female participants exhibited a larger TSC benefit than male participants (77% vs. 47%, p = 0.025), while older and younger participants did not differ significantly. A published erratum clarified minor analytical-table corrections without altering the principal effect estimates (37). The study was graded Level of Evidence 1a, and remains the first prospective double-blind RCT to evaluate threshold-matched conditioning in sensorineural hearing loss.
3.3. Cochlear model and audiometric apparatus underpinning TSC
Translating the bench-side conditioning concept into a deployable clinical instrument required an audiometric and signal-processing pipeline capable of (i) resolving the patient's hearing threshold at sub-octave frequency resolution, (ii) selecting a conditioning band that matches the most affected cochlear region, and (iii) delivering the stimulus at strictly sub-threshold intensity without driving secondary acoustic trauma. Objective automated audiometry based on the wave-V and SN10 peaks of the auditory brainstem response (54) and a cochlear-model-based apparatus that divides the audible band at 1/k-octave resolution (55) provide the relevant technical basis; a complementary preprint provides a high-resolution stochastic model of tinnitus loudness derived from algorithmic pure-tone audiometry at 134 frequency bands (1/24-octave resolution) in 196 chronic tinnitus patients (56), the methodologically relevant precedent for the extended high-frequency audiometry recommended for the prospective aircrew cohort (Section 6). We cite this engineering background for completeness only; the CCSI framework is independent of any specific device implementation.
3.4. Why 3, 4, and 6 kHz?
The TSC region was empirically narrowed to the 3, 4, and 6 kHz options in the Kwak and Kwak 2020 protocol on the basis of the participants' audiometric profile: the worst observed pure-tone threshold among patients with sensorineural hearing loss consistently localized within this band, mirroring the dominant frequency band of noise-induced and presbycusis-related cochlear damage. The present paper recasts this empirical selection as a derivable consequence of multi-hazard cochlear physiology: under the convergence hypothesis advanced in Section 1 and developed quantitatively in Section 4, 3–6 kHz emerges naturally as the geometric overlap of noise, hypoxia and radiation vulnerability. Section 5 operationalises this overlap into a frequency-resolved score that selects the conditioning band from the operational flight profile rather than from a previously administered audiogram, motivating a prospective evaluation of TSC as a candidate preventive paradigm in aircrew.
4. Hypothesis: convergent 3–6 kHz vulnerability
4.1. Formal statement
The central hypothesis of the present paper can be stated as follows. Consider the auditory frequency axis discretized into eight standard audiometric bands kHz, and consider three mechanism-distinct cochlear vulnerability kernels: gN(f) for cabin acoustic noise, gH(f) for hypobaric hypoxia, and gR(f) for ionizing radiation. Each kernel is parameterized as a Gaussian peak in log-octave frequency space,
| (2) |
with kernel parameters (μX, σX) calibrated to the mechanistic-evidence corpus reviewed in Section 2: (μN, σN) = (4kHz, 0.8oct) for the classical noise-notch (1, 2), (μH, σH) = (3kHz, 1.0oct) for the hypobaric-hypoxia threshold-shift band (10–12), and (μR, σR) = (6kHz, 0.9oct) for the high-frequency-biased ribbon-synapse damage observed in head-and-neck radiotherapy (28–30).
Define the per-frequency convergence index
| (3) |
i.e. the geometric mean of the three kernels.
Convergence hypothesis (H1): The geometric-mean convergence index gconv(f) attains its maximum within the Kwak & Kwak clinical TSC region kHz, i.e.
| (4) |
Null hypothesis (H0): The argmax of gconv(f) falls outside the clinical TSC region, indicating that the empirical Kwak & Kwak frequency selection is not derivable from multi-hazard cochlear physiology and must be motivated solely by post-hoc audiometric observation.
4.2. Numerical evaluation
Evaluating Equation 3 on a logarithmically spaced fine grid (300 points over 0.5–12 kHz) yields a smooth curve peaking at f* = 4.23 kHz with on the normalized scale; the analytical solution yields the same value to three decimal places. The full-width at half-maximum spans 2.06–8.72 kHz, fully containing the clinical TSC region; the curve and the underlying three kernels are plotted in Figure 2C. Restricted to the discrete audiometric grid , the argmax lies at 4 kHz, which is the central element of the clinical TSC set . The per-band values of gconv on the discrete grid are {0.002, 0.059, 0.434, 0.778, 0.906, 0.774, 0.533, 0.217} for f ∈ {0.5, 1, 2, 3, 4, 6, 8, 12} kHz, respectively. This calculation is not a statistical test of H1 but a formal consistency check showing that the three independently motivated kernel priors converge inside the clinically used TSC frequency set; the substantive content of H1 is discussed in Section 4.3.
4.3. Why the hypothesis is non-trivial
A reasonable objection is that the kernels in Equation 2 are themselves set from the same audiometric literature that defines , making H1 tautological. We acknowledge this and clarify what the hypothesis does and does not claim.
The kernel peak frequencies μN, μH, μR are not derived from the Kwak and Kwak clinical protocol; they are independently calibrated to noise-induced audiometric prevalence [μN = 4 kHz from Falcão n = 3, 130 (1)], hypobaric-hypoxia threshold-shift maps [μH = 3 kHz from ADEMED 2011 and Singh 2021 (10, 11)], and ribbon-synapse damage maps from radiotherapy [μR = 6 kHz from Liu 2022 (30) and the high-frequency-biased prevalence pattern of Theunissen (29)]. The convergence onto 3–6 kHz is therefore a consequence of three independent mechanistic literatures rather than a circular reading of the clinical protocol.
The non-trivial claim is the geometric overlap of three kernels with different peak frequencies (3, 4, and 6 kHz) within a finite band that coincides with the empirical clinical selection set. A natural counter-hypothesis would be a noise-only or hypoxia-only single-kernel argmax that falls outside 3–6 kHz, which would render a clinical-only construct. H1 rules out this alternative.
A further non-trivial claim, developed quantitatively in Section 5, is that the kernel-weighted multi-hazard score shifts the argmax in a profile-specific way across the clinical TSC set. The framework therefore generates a profile-level prediction (3 vs. 4 vs. 6 kHz) that is testable in any prospective audiometric cohort.
4.3.1. Monte-Carlo test of non-triviality
To quantify the tautology objection directly we performed a Monte-Carlo randomization of the kernel parameters (N = 2 × 105 draws) and recorded how often the discrete-grid argmax of gconv falls inside kHz. Under mechanistic uncertainty, peaks drawn uniformly within the literature-reported ranges (μN ∈ [3.5, 4.5], μH ∈ [2.5, 3.5], μR ∈ [5, 7] kHz, σX ∈ [0.7, 1.1] oct), the argmax lies inside in 100.0% of draws and lands specifically at 4 kHz in 99.2%, confirming that the convergence is robust to the exact kernel specification rather than an artifact of a single parameter choice. Under an unconstrained null, all three peaks drawn log-uniformly over the 1–8 kHz audiometric range, the argmax falls inside in only 64.6% of draws and at 4 kHz in only 23.1%. The contrast is informative and we report it without overstatement: landing somewhere in 3–6 kHz is only moderately non-trivial (a 64.6% chance baseline reflects the central position of the TSC bands on the audiometric grid), but the specific concentration at 4 kHz under mechanistically constrained kernels (99.2% vs. a 23.1% chance baseline, a 4.3 × enrichment) is strongly non-trivial and is the quantitative core of the convergence claim. The randomization routine and results are released as null_test.py and null_test_results.json in the deposit.
4.4. Relationship between gconv(f) and the operational CCSI
The convergence index gconv(f) in Equation 3 and the Cumulative Cochlear Stress Index CCSI(f) that we develop quantitatively in Section 5 are formally distinct mathematical objects with complementary roles. The convergence index is the geometric mean of the three vulnerability kernels and is dose-independent; it captures the intrinsic frequency-domain overlap among the three mechanism-distinct pathways and is the natural object on which hypothesis H1 is stated, as it tests whether the three kernels co-localize on a clinically defined frequency set regardless of how much each pathway actually contributes in a given operational scenario. The CCSI of Equation 9, in contrast, is an operational, dose-weighted arithmetic sum that multiplies each kernel by its corresponding per-segment hazard dose (DR, DH, DN) and a mixing weight wX; its argmax is profile-specific and shifts across the clinical set as the relative dose magnitudes change between aircrew operational profiles. We use gconv to test the convergence hypothesis H1 and CCSI to derive the per-profile TSC recommendation. The two objects coincide in the limiting case where the three normalized doses are equal and the weights are uniform; outside this limit they encode different information.
4.5. Calibration assumptions and limitations of the kernels
The kernel parameters (μX, σX) in Equation 2 are chosen to summarize the dominant frequency emphasis of each pathway as reported in the cited literature, but they should be regarded as informed prior choices rather than as quantitatively fitted parameters. The peak μN = 4 kHz is well-anchored in the aircrew NIHL literature (1, 2). The peak μH = 3 kHz reflects the lower-mid-frequency emphasis of the hypobaric-hypoxia threshold-shift band reported by ADEMED 2011 (10) and the persistent 2–4 kHz elevation reported by Singh et al. (11); the choice of a single μH = 3 kHz is a working summary of a band-spread effect rather than a sharp localization. We further note that ADEMED 2011 acclimatized volunteers at 5,300 m, whereas the regulatory cabin-altitude cap corresponds to ≈2,440 m; the alveolar hypoxia index at the cabin cap (H≈0.45) is substantially milder than at the ADEMED altitude (H≈0.74 at 5,300 m, an ≈40% reduction at the regulatory cap), so μH and the hypoxia weighting should be read as a transfer of the threshold-shift frequency emphasis rather than a dose-matched extrapolation. This altitude gap is carried as an explicit uncertainty and is spanned by the μH ∈ [2.5, 3.5] kHz randomization in the Monte-Carlo robustness test. The peak μR = 6 kHz reflects the high-frequency-biased ribbon-synapse damage demonstrated by Liu et al. (30) and the monotonic high-frequency rise in radiotherapy-induced SNHL prevalence reported by Theunissen et al. (29); the value μR = 6 kHz positions the radiation kernel toward the high-frequency end without collapsing onto the 8–12 kHz range where audiometric coverage in the eligible aircrew is sparse. The widths σX (0.8–1.0 octave) are chosen so that all three kernels retain non-negligible support across 2–8 kHz, consistent with the broad audiometric signatures reported in each source literature; they are not independently fitted, and the impact of alternative widths is absorbed into the sensitivity analysis of Section 5.5.
5. Computational framework: CCSI
To mitigate the commercial conflict of interest declared at the end of the manuscript, the framework was developed under explicit independence safeguards. (i) The synthetic-dataset generation, the radiation and hypoxia dosimetry, the CCSI implementation, the machine-learning identifiability check, and the sensitivity and Monte-Carlo analyses were carried out by the non-conflicted, Chemical, Biological, Radiological and Nuclear (CBRN) Defense Research Institute-affiliated authors, who retained sole custody of the analysis code and input data. (ii) The authors affiliated with the commercial TSC developers (Sound Vaccine/AudioCardio) contributed clinical and audiometric domain expertise, the TSC clinical protocol (Section 3) and the literature anchoring of the cochlear-vulnerability kernels, but did not implement or run the dosimetric, machine-learning, or statistical analyses; moreover, the convergence result is robust to the kernel specification (Monte-Carlo test, Supplementary material), bounding the influence of any domain-expert kernel choice on the conclusions. (iii) The quantitative results, the conclusions, and the profile-specific clinical recommendation were drafted and approved by the non-conflicted authors. (iv) No commercial product data, device, or funding was used; the complete code and data are released openly (see the Data Availability Statement) so that every reported number can be reproduced independently of any author.
5.1. Operational inputs and physics dose proxies
For an aircrew profile indexed by cruise altitude h (km), flight-hours per segment t (h), geomagnetic cut-off rigidity Rc (GV), heliocentric potential HCP (MV) and cabin A-weighted equivalent level LAeq (dBA), we define three physics-based per-segment hazard “doses”.
5.1.1. Radiation dose
We use a screening-level empirical approximation to the CARI-7 dose rates (24), parameterized as the closed-form altitude–dose relation of Equation 1 multiplied by geomagnetic-latitude and solar-modulation factors:
| (5) |
with , a = 0.0994, n = 1.289, Rc, ref = 9.96 GV (Korean Peninsula reference), and a solar-modulation factor f⊙(HCP) = 1+0.13(HCPmax−HCP)/(HCPmax−HCPmin) with HCPmax = 1141 MV and HCPmin = 270 MV. The per-segment dose DR is normalized by 1000μSv so that one normalized unit corresponds to a typical aircrew yearly exposure of ~1 mSv at FL300.
5.1.2. Hypoxia dose
The cabin altitude hcab = min(h, hcap) with hcap = 2.44 km is fed into a simplified alveolar gas equation that returns the estimated alveolar oxygen tension PAO2,
| (6) |
with mmHg, FiO2 = 0.2095, PaCO2 = 40 mmHg, RQ = 0.8; arterial PaO2 is somewhat lower due to the A–a gradient and is not separately modeled here. The alveolar hypoxia index H(h) = 1−PAO2(hcab)/PAO2(0) is then time-integrated to yield the per-segment hypoxia dose
| (7) |
normalized so that one unit corresponds to an 8-h flight at the cap-equivalent hypoxia index Hcap = 1 − 55/99 ≈ 0.45 computed from Equation 6 at the regulatory cap altitude.
5.1.3. Noise dose
The cabin acoustic environment is summarized by a single LAeq, above a 65 dBA reference floor, and integrated over the flight segment,
| (8) |
normalized so that one unit corresponds to an 8-h segment at LAeq = 95 dBA.
5.2. Cumulative cochlear stress index
The frequency-resolved Cumulative Cochlear Stress Index combines the three hazard doses with the vulnerability kernels of Equation 2 via fixed mixing weights w = (wR, wH, wN):
| (9) |
where the inputs (h, t, Rc, HCP, LAeq) enter through the hazard doses DR, DH, DN via Equations 5–8, and the kernels gX(f) are given by Equation 2. with wR, wH, wN≥0 and wR + wH + wN = 1.
The default weighting reflects the relative prior confidence the literature supports for each hazard pathway and is intentionally distinct from the per-flight dose magnitudes that the framework generates. The noise pathway is the most empirically supported (decades of audiometric surveys in aircrew), yielding wN = 0.45; the radiation pathway has strong mechanism evidence at therapeutic doses (Gy-scale fractionated radiotherapy) but no direct epidemiological link at the μSv–mSv scale of cruise exposure, so wR = 0.35 should be read as an illustrative prior placeholder, not as an evidence-derived biological weight; sensitivity to this choice is examined in Section 5.5. To preserve independence from the declared commercial conflict of interest, all mixing weights were assigned by the non-conflicted authors (K. Kang, E. Choi, C.-M. Yang, J. Yoo, S. Kim and D.-H. Lee), and the radiation-excluded scenario (wR = 0) of Section 5.5 confirms that the conclusions hold with the radiation weight removed entirely. The hypoxia pathway has the mechanistic support of ADEMED 2011 but is partially clipped by the regulatory cabin-altitude cap, yielding wH = 0.20. The robustness analyses below confirm that the convergence-into-TSC claim does not depend on this weight assignment.
5.2.1. Resulting magnitude breakdown
For a representative mid-latitude long-haul profile (FL360, Rc = 9.96 GV, HCP = 1141 MV, t = 8 h, LAeq = 78 dBA), the normalized per-segment doses are DR≈0.014, DH≈1.00 and DN≈0.43 under the cap-anchored hypoxia normalization of Equation 7. The 4 kHz CCSI contribution breakdown is DNNN≈0.195 (noise, 51% of total), DHHH≈0.183 (hypoxia, 48%) and DRRR≈0.004 (radiation, ~1%). Noise and hypoxia therefore contribute comparably at 4 kHz under default weights, with radiation entering as a small mechanism-bearing term consistent with the limited evidence at aviation doses. For the short-haul military-fighter/rotary profile (t = 1.5 h, LAeq = 92 dBA), the same accounting yields a noise-dominated breakdown in which the time-integrated hypoxia advantage shrinks and the noise contribution overtakes the hypoxia contribution at 4 kHz. The framework is therefore not exclusively noise-driven: under long-haul profiles noise and hypoxia are comparable, while under short-haul high-noise profiles the noise pathway dominates. In both regimes the argmax of CCSI within the clinical TSC set remains controlled by the geometric overlap of the three kernels rather than by any single pathway, which is the central operational consequence of the convergence hypothesis H1.
Sensitivity analyses across alternative weight choices reproduce the 3–6 kHz argmax robustly (Section 5.5); the framework's qualitative output therefore does not hinge on the exact weight values.
5.3. Synthetic dataset
To enable per-feature, per-band interpretation of the framework and to visualize the operational envelope (Figures 1B, 3B, C), we constructed a synthetic dataset of n = 500 aircrew flight profiles by uniform sampling over operational ranges of the five inputs: h ∈ [3.0, 12.2] km, t ∈ [1, 12] h, Rc ∈ [0.5, 17] GV, HCP ∈ [270, 1141] MV, and a mild altitude-dependent cabin-noise term anchored to GAO 2018 (, clipped to [60, 100] dBA). Each sample is labeled by Equation 9 with σ = 5% multiplicative Gaussian noise applied to the per-band CCSI labels to represent intra-population biological variability and CARI-7-grid interpolation uncertainty. The dataset and the generation routine are released through the Zenodo deposit referenced in the Data Availability Statement section. A machine-learning identifiability check trained on this dataset is reported in Supplementary material; it is an internal model-recovery analysis rather than part of the substantive argument of the main text.
Figure 3.

CCSI model architecture and synthetic dataset. (A) Schematic of the input–proxy–kernel–output flow. (B) Marginal distributions of the four primary input features over n = 500 uniformly sampled aircrew profiles. (C) Per-frequency-band distribution of CCSI labels, with the 3–6 kHz Kwak TSC region shaded.
5.4. Model architecture summary
Figure 3 summarizes the framework. Panel A is the schematic of the five operational inputs, the three physics dose proxies (Equations 5–8), the three vulnerability kernels (Equation 2), and the final weighted sum (Equation 9). Panel B reports the marginal distributions of the four primary input features over the n = 500 synthetic sample, confirming uniform coverage of the operational envelope. Panel C shows the per-frequency-band distribution of CCSI labels, with a clear maximum in the 3–6 kHz band; the inter-quartile spread within each band reflects the variance contribution of h, t and LAeq.
5.5. Sensitivity to mixing weights
The mixing weights w in Equation 9 are intentionally specified as fixed prior weights rather than as free fitted parameters. To characterize the robustness of the profile-level prioritization against this prior choice, we evaluated Equation 9 for the four representative operational profiles of Table 1 under six mixing-weight scenarios that span the physiologically defensible region of the weight simplex. For each profile × weight combination we computed the global argmax of CCSI over the full discrete audiometric grid kHz, not restricted to kHz, so that a non-trivial robustness check is performed: a result would not be true by construction. The result is summarized in Table 2.
Table 1.
Representative aircrew operational profiles used for CCSI prioritization.
| Profile | h (km) | Rc (GV) | HCP (MV) | t (h) | LAeq (dBA) |
|---|---|---|---|---|---|
| Polar long-haul | 11.0 | 1.00 | 600 | 10.0 | 78 |
| Mid-latitude long-haul | 11.0 | 9.96 | 1141 | 8.0 | 78 |
| Domestic short-haul | 8.5 | 9.96 | 1141 | 1.5 | 80 |
| Military fighter/rotary | 6.0 | 9.96 | 1141 | 1.5 | 92 |
Columns: cruise altitude h, geomagnetic cut-off rigidity Rc, heliocentric potential HCP, per-segment flight hours t, cabin LAeq.
Table 2.
Sensitivity of the global CCSI argmax (kHz; over the full discrete audiometric grid kHz, not restricted to ) to the mixing weights w = (wN, wH, wR) across the four aircrew profiles of Table 1.
| Weight scenario | (wN, wH, wR) | Polar long-haul | Mid-lat long-haul | Domestic short-haul | Military fighter | Pattern summary |
|---|---|---|---|---|---|---|
| Default | (0.45, 0.20, 0.35) | 4 | 4 | 4 | 4 | 4/4/4/4 |
| Balanced | (0.40, 0.30, 0.30) | 4 | 3 | 4 | 4 | 4/3/4/4 |
| Noise-extreme | (0.50, 0.10, 0.40) | 4 | 4 | 4 | 4 | 4/4/4/4 |
| Radiation-extreme | (0.30, 0.20, 0.50) | 4 | 4 | 4 | 4 | 4/4/4/4 |
| Hypoxia-extreme | (0.30, 0.50, 0.20) | 3 | 3 | 3 | 3 | 3/3/3/3 |
| Radiation-excluded | (0.69, 0.31, 0.00) | 4 | 4 | 4 | 4 | 4/4/4/4 |
All 24 cells lie within kHz, providing a non-tautological robustness check. Per-cell CCSI values for all eight bands are released in sensitivity_table.csv.
Two observations follow. First, in all 24 profile × weight combinations the global CCSI argmax over the full audiometric grid lies inside kHz; the convergence-into-TSC-region claim is therefore robust to the weight prior in a non-tautological sense. Second, the precise band selection within is weight-sensitive at the extremes: under default, noise-extreme and radiation-extreme priors the argmax falls on 4 kHz across all four profiles, while under a hypoxia-extreme prior it shifts to 3 kHz across all four. The balanced prior produces a mixed 4/3/4/4 pattern, with the mid-latitude long-haul profile, where time-integrated hypoxia and noise are most evenly matched, being the only one that shifts. No weight scenario in the simplex examined here places the global argmax outside . Critically, a radiation-excluded scenario (wR = 0, with the noise and hypoxia weights renormalized to 0.69:0.31) reproduces the 4 kHz argmax for all four profiles, demonstrating that the convergence and the resulting TSC recommendation do not depend on the radiation axis, the most heavily caveated and commercially sensitive component, at all.
The pattern in Table 2 clarifies what the framework does and does not assert. The convergence hypothesis H1 (Section 4) is robust across the whole weight simplex examined here, in the non-tautological sense that the global argmax, unconstrained to the TSC set, lands inside in every cell. The clinical recommendation of the precise band within , however, is sensitive to the weighting prior; under default weights the framework selects 4 kHz for all four representative profiles, while a hypoxia-dominant prior shifts the selection uniformly to 3 kHz. For operational deployment we therefore recommend reporting the recommended frequency under the default weights together with the extreme-prior bracket as an uncertainty range.
5.6. Aircrew profile prioritization
Application of Equation 9 to four representative operational profiles defined in Table 1 (and instantiated in the released code) produces the CCSI heatmap of Figure 4A and the per-profile CCSI–frequency overlay of Figure 4B; the recommended TSC region per profile, restricted to the clinical set kHz, is reported in Figure 4C. Under the default literature-prior weighting all four profiles place the within- argmax at 4 kHz, reflecting the geometric overlap of the three vulnerability kernels at the canonical noise-notch frequency. The 3 kHz band is the closest neighbor: at 4 kHz it lags by under 1–3% of the CCSI at the argmax across these profiles (see sensitivity_table.csv), so under a hypoxia-dominant prior the selection shifts uniformly to 3 kHz (Table 2). The 4 kHz default selection is consistent with the dominant 4 kHz noise-notch pattern reported in both civilian and military aircrew cohorts (1, 2). Profile-specific clinical implications and the rationale for reporting the recommendation as a default-plus-bracket are developed in Section 6.
Figure 4.

TSC region prioritization across representative aircrew operational profiles. (A) CCSI heatmap of four profiles (polar long-haul, mid-latitude long-haul, domestic short-haul, military fighter/rotary) by frequency band; dashed verticals mark the Kwak TSC region. (B) Per-profile CCSI–frequency curves overlaid. (C) Recommended TSC region per profile within the clinical 3/4/6 kHz set; the filled red bar indicates the selected target frequency, and the boxed label above each profile reports the recommendation.
6. Implications and research agenda
The CCSI framework developed in Sections 4–5 provides three distinct categories of operational implication, each of which suggests a concrete next step.
6.1. Translational implication: TSC as a candidate preventive intervention in aviation medicine
The Kwak and Kwak 2020 clinical protocol selects the TSC target frequency from the patient's worst-threshold band within 3, 4, or 6 kHz (35). The CCSI framework reproduces this clinical decision rule from the operational flight profile alone, without requiring a pre-existing audiogram. Across the four representative profiles in Figure 4C, the CCSI argmax under default weights falls on 4 kHz for all four representative profiles, in agreement with the dominant 4 kHz noise-notch pattern reported in both civilian and military aircrew cohorts (1, 2). Under a hypoxia-dominant weighting the recommendation shifts uniformly to 3 kHz (Table 2), and the 3 kHz band remains within 1–3% of the 4 kHz argmax across all four default-weight profiles. The framework therefore identifies 4 kHz as the default target and 3 kHz as a defensible alternative when hypoxia exposure is judged dominant, suggesting that the CCSI argmax could serve as a profile-specific prior in a prospective evaluation of TSC.
Two operational extensions follow. First, for long-haul commercial aircrew already enrolled in occupational audiometric surveillance, the CCSI argmax provides a flight-profile-derived recommendation that can be cross-checked against the audiometric finding when surveillance begins to detect threshold drift; the CCSI prior thus functions as a candidate pre-emptive target rather than a reactive one, conditional on prospective audiometric validation. Second, for short-haul or rotary-wing crews in whom long-haul-style audiometric surveillance is operationally impractical, the CCSI-recommended frequency provides a hypothesis-generating target on the basis of the cumulative LAeq in the dominant flight envelope, without requiring a per-individual audiogram.
Practically, the CCSI is intended to complement, not replace, existing hearing-conservation practice. Within current occupational programs, periodic pure-tone and extended high-frequency audiometry, noise dosimetry, and fitness-to-fly review, a validated CCSI could (i) triage surveillance intensity, flagging the routes and crews (e.g. polar long-haul, high-LAeq rotary) whose profiles predict the steepest 3–6 kHz risk; (ii) supply a pre-audiometric prognostic prior that is cross-checked against, and updated by, each surveillance audiogram, sharpening early detection of threshold drift; and (iii) guide frequency-targeted countermeasures, scheduling or hearing-protection adjustments and, where indicated, a profile-matched TSC target, ahead of measurable loss. In this role the framework adds a frequency-resolved, exposure-driven dimension to programs at present triggered reactively by audiometric change.
6.2. Epidemiological implication: a prospective aircrew audiometric cohort
The most direct empirical test of the convergence hypothesis would be a prospective audiometric cohort that recruits aircrew across the four operational profiles characterized in Figure 4 and follows their pure-tone thresholds longitudinally over a period long enough to resolve cumulative exposure. Two design features are critical for such a cohort.
First, the audiometric protocol must include extended high-frequency audiometry (9–18 kHz), because high-frequency damage from cumulative exposure consistently precedes conventional pure-tone loss (2, 7, 8). High-resolution automated audiometry at sub-octave resolution, as described in the companion preprint (56), provides a methodologically suitable testing approach; we report this engineering precedent without endorsing any specific commercial platform.
Second, the cohort must record the four CCSI input features (cumulative flight-hours, route-distribution-derived Rc, solar-cycle phase via HCP, and route-typical LAeq). The screening-level empirical approximation of Equations 1–5 reduces the radiation component to closed-form inputs that can be derived from flight-log metadata alone, avoiding the per-flight dose reconstruction otherwise required.
Third, the cohort should be powered for the primary frequency-shift endpoint. As an illustrative benchmark, detecting a between-arm difference equivalent to the Kwak and Kwak 2020 amelioration contrast (78% vs. 44%) at α = 0.05 (two-sided) with 80% power requires ≈16 evaluable participants per arm by a two-proportion test; allowing for ~20% attrition and stratification across the four operational profiles points to a target enrolment of ~150 aircrew. A formal power analysis indexed to the profile-specific CCSI argmax is the natural next design step.
Cross-validation against the existing Pukkala Nordic cohorts (19–21), which record cumulative radiation dose but not audiometric outcomes, would require audiometric retro-fitting, which is not generally feasible. A new prospective cohort with both inputs and outcomes is the cleaner study design.
6.3. Regulatory implication: dose-aware screening thresholds
The CARI-7-derived screening approximation of Equations 1–5 implies that polar long-haul operations systematically exceed the ICRP public reference level of 1 mSv yr−1. The companion CCSI framework presented here adds a frequency-resolved auditory dimension to this observation and supports the case for systematic cochlear monitoring on the subset of routes that combine Rc < 4.5 GV (i.e. northern Europe and polar) with sustained cruise altitude above ~ 11 km. Importantly, exceedance of the radiation reference level is not by itself evidence of clinically relevant cochlear harm; rather, it is a defensible trigger for enhanced monitoring of the very pathway (3–6 kHz cochlear vulnerability) that the convergence hypothesis predicts.
6.4. Methodological extensions
Three modeling refinements are within scope of the present framework. First, the hypoxia component of CCSI is presently parameterized through the cabin-altitude regulatory cap, which makes the hypoxia contribution near-constant across cruise altitudes within the commercial envelope and limits the discriminative power of the hypoxia feature in the ML decomposition (Supplementary Figure S1C). A prospective extension that records actual cabin-altitude variation across operators and aircraft types (which is known to span 6,000–8,000 ft equivalent) would restore variance to this feature and clarify its contribution.
Second, the cabin-noise input is presently a single LAeq value, which collapses spectral content into a single number. An octave-band-resolved noise input, fed through a band-matched vulnerability kernel rather than a single 4 kHz Gaussian, would sharpen the noise-component frequency signature and likely separate the wide-body cabin (engine-broadband) from the fighter/rotary cockpit (gear-discrete and pulsed) operational patterns more cleanly.
Third, the radiation component is presently anchored to the CARI-7-derived screening approximation of Equations 1–5 and assumes that the cochlear damage function follows a Gaussian band centered at 6 kHz, inferred from the high-dose radiotherapy literature (28–30). Validation of this extrapolation at low chronic doses is, as noted in Section 2.5, not currently available, and a calibration study using accelerator-based GCR analog (45, 46) in animal models would be a natural follow-up. A further extension is to couple the CCSI score to biomechanical auditory-periphery and auditory-nerve models (57–59), replacing the Gaussian vulnerability kernels with mechanistically derived frequency weightings.
6.5. Assumptions and limitations
The framework rests on explicit assumptions that bound its interpretation. (i) It is computational and hypothesis-generating: all results derive from a closed-form model and an n = 500 synthetic dataset, with no new audiometric measurements. (ii) The vulnerability kernels gX(f) are informed prior choices anchored to the cited literature, not parameters fitted to data; their robustness is probed by Monte-Carlo randomization (Section 4.3) rather than estimated with confidence intervals. (iii) The hypoxia term is clipped by the 14 CFR 25.841 cabin-altitude cap, making it near-constant across the commercial cruise envelope, and its kernel is transferred from higher-altitude (5,300 m) data (Section 4.5). (iv) The radiation axis extrapolates a frequency signature from Gy-scale radiotherapy to mSv-scale cruise exposure and is treated as exploratory, with a direct low-dose cochlear evidence base presently absent. (v) The machine-learning step is an internal model-recovery / identifiability check on model-generated labels, not a biological validation. (vi) The framework yields a frequency prior; it does not establish that cosmic radiation harms the aircrew cochlea, nor that TSC prevents aircrew hearing loss, both require the prospective evaluation outlined above. None of these limitations is concealed: the design goal is a transparent, falsifiable decision-support prior, not a validated clinical instrument.
7. Conclusions
We have introduced and operationalized a transparent, physics- and audiology-informed framework that integrates three mechanism-distinct cochlear stressors of the aircrew operational environment (cabin acoustic noise, hypobaric hypoxia under regulatory cabin-pressure caps, and altitude-dependent cosmic ionizing radiation) into a single frequency-resolved score, the Cumulative Cochlear Stress Index (CCSI). Four conclusions follow.
Convergence band. Across the noise, hypoxia and radiation literatures, the dominant frequency band of cochlear vulnerability in aircrew is 3–6 kHz, with peak emphasis shifting modestly across the three pathways but with a robust geometric overlap. This convergence band coincides exactly with the empirical TSC region (3, 4, or 6 kHz) defined by the Kwak & Kwak 2020 randomized controlled trial (35).
Model transparency. The CCSI score is a closed-form weighted sum of three physics- and physiology-derived dose proxies, each multiplied by a frequency-resolved Gaussian vulnerability kernel in log-octave space. The radiation component is anchored to a screening-level approximation to the CARI-7 dose model (24) and is benchmarked against published in-flight aircrew dosimetry (27, 38); the hypoxia component is derived from the alveolar gas equation under the FAA cabin-altitude regulatory cap; the noise component is an A-weighted occupational exposure term. No black-box approximation is used.
Robustness and sensitivity. A structured sensitivity analysis evaluating the global CCSI argmax over the full audiometric grid kHz finds the argmax inside kHz in all 24 profile × weight cells, and a Monte-Carlo randomization of the kernel parameters within literature bounds reproduces the 4 kHz convergence in 99.2% of draws vs. a 23.1% chance baseline, providing a non-tautological robustness check on the convergence claim. A machine-learning identifiability check (Supplementary material) confirms that each input feature activates the band predicted by its underlying physiology; because its regression labels are themselves CCSI values, it is an internal model-recovery check rather than a biological validation; the high R2 should not be interpreted as evidence of biological validity, or of predictive accuracy for real-world audiometric outcomes.
Clinical translation. Under the default literature prior weighting the CCSI argmax within falls on 4 kHz for all four representative aircrew profiles, in agreement with the established 4 kHz noise-notch pattern in civilian and military aircrew (1, 2), with 3 kHz emerging as the alternative under a hypoxia-dominant weighting. The framework thereby identifies a candidate profile-specific TSC target that extends the current audiogram-triggered curative use of TSC toward a hypothesis-driven prospective evaluation indexed by the operational flight profile.
The framework is designed to support, rather than replace, the prospective audiometric cohort that will ultimately be required to test the convergence hypothesis directly; the explicit cohort design implications are reported in Section 6.
Acknowledgments
The authors thank the Korea Astronomy and Space Science Institute (KASI) and the Republic of Korea Air Force for the in-flight dosimetry data that anchors the radiation component of the present framework (27).
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This research was supported by the Korea Environmental Industry and Technology Institute (KEITI) through the Field-Driven Environmental Technology Commercialization R&D Program (RS-2026-25524751), funded by the Ministry of Climate, Energy and Environment of the Republic of Korea.
Edited by: Maura Cosetti, Icahn School of Medicine at Mount Sinai, United States
Reviewed by: Xin Gong, Wushan County People's Hospital of Chongqing, China
Ningning Shao, Geneva Foundation, United States
Abbreviations: CCSI, cumulative cochlear stress index; TSC, threshold sound conditioning; SNHL, sensorineural hearing loss; NIHL, noise-induced hearing loss; TTS, temporary threshold shift; CARI-7, Civil Aerospace Medical Institute Radiobiology code (version 7); GCR, galactic cosmic radiation; HCP, heliocentric potential; Rc, geomagnetic cut-off rigidity; LAeq, A-weighted equivalent continuous sound level; FWHM, full width at half maximum; PAO2/PaO2, alveolar/arterial oxygen tension; FiO2, fraction of inspired oxygen; RQ, respiratory quotient; ABR, auditory brainstem response; RF, random forest; GB, gradient boosting; CV, cross-validation; MARE, mean absolute relative error; FL, flight level; ICRP, International Commission on Radiological Protection; NAIRAS, Nowcast of Atmospheric Ionizing Radiation System; NIOSH, National Institute for Occupational Safety and Health; OSHA, Occupational Safety and Health Administration; GAO, U.S. Government Accountability Office; RCT, randomized controlled trial.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
DL: Resources, Writing – original draft, Writing – review & editing. SJ: Writing – original draft, Writing – review & editing. KK: Data curation, Formal analysis, Writing – original draft, Writing – review & editing. EC: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. C-MY: Investigation, Validation, Writing – original draft, Writing – review & editing. JY: Data curation, Investigation, Writing – original draft, Writing – review & editing. SKi: Data curation, Investigation, Writing – original draft, Writing – review & editing. SKw: Conceptualization, Supervision, Writing – original draft, Writing – review & editing. D-HL: Conceptualization, Methodology, Formal analysis, Supervision, Project administration, Funding acquisition, Validation, Writing – original draft, Writing – review & editing.
Conflict of interest
DL (Sound Vaccine), SJ, and SKw are employees or affiliates of Sound Vaccine, Inc. (Daejeon, Republic of Korea) and/or AudioCardio, Inc. (Santa Monica, CA, USA), commercial entities that develop threshold sound conditioning (TSC) products, and are co-inventors on the TSC-related US patents and applications cited in Section 3. The present manuscript does not report data from any Sound Vaccine or AudioCardio commercial product and does not endorse a specific commercial TSC device; the CCSI framework is published as an open computational tool independent of any product. The computational dosimetry, ML implementation, sensitivity analysis and manuscript preparation were conducted by the CBRN team independently of any Sound Vaccine or AudioCardio commercial funding. To further mitigate this conflict, the clinical TSC recommendation and its interpretation were led and verified by the non-conflicted authors (KK, EC, C-MY, JY, SKi, and D-HL), who hold no financial interest in any TSC product; the conflicted authors (DL, SJ, and SaK) contributed only the TSC clinical-protocol description and the engineering background of Section 3.
Correction note
This article has been corrected with minor changes. These changes do not impact the scientific content of the article.
Generative AI statement
The author(s) declared that Generative AI was used in the creation of this manuscript. During the preparation of this work the authors used a generative AI assistant (Anthropic Claude) to support language editing, analysis-code generation, and LATEX formatting. After using this tool, the authors reviewed, verified, and edited all resulting content, including text, code, citations, and figures, and take full responsibility for the content of the publication. No generative AI tool is listed as an author, in accordance with Frontiers policy, as such tools cannot be accountable for the work.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2026.1903374/full#supplementary-material
References
- 1.Falcão TP, Schütz GE, Luiz RR. Audiometric profile of civilian pilots according to noise exposure. Rev Saúde P'ublica. (2014) 48:790–6. doi: 10.1590/S0034-8910.2014048005256 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kuo CY, Hung CL, Chen HC, Shih CP, Lu RH, Chen CW, et al. The immediate and long-term impact of military aircraft noise on hearing: a cross-sectional comparison of fighter pilots and ground staff. Int J Environ Res Public Health. (2021) 18:2982. doi: 10.3390/ijerph18062982 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lindgren T, Wieslander G, Dammström BG, Norbäck D. Hearing status among commercial pilots in a Swedish airline company. Int J Audiol. (2008) 47:515–19. doi: 10.1080/14992020802064633 [DOI] [PubMed] [Google Scholar]
- 4.Lindgren T, Wieslander G, Dammström BG, Norbäck D. Hearing status among cabin crew in a Swedish commercial airline company. Int Arch Occup Environ Health. (2009) 82:887–92. doi: 10.1007/s00420-008-0372-7 [DOI] [PubMed] [Google Scholar]
- 5.Wagstaff AS, Arva P. Hearing loss in civilian airline and helicopter pilots compared to air traffic control personnel. Aviat Space Environ Med. (2009) 80:857–61. doi: 10.3357/ASEM.1991.2009 [DOI] [PubMed] [Google Scholar]
- 6.Aljaber M, Alharbi H. Association of flying time with hearing loss in military pilots. Saudi J Med Med Sci. (2018) 6:155–9. doi: 10.4103/sjmms.sjmms_10_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kuronen P, Sorri MJ, Pääkkönen R, Muhli A. Temporary threshold shift in military pilots measured using conventional and extended high-frequency audiometry after one flight. Int J Audiol. (2003) 42:29–33. doi: 10.3109/14992020309056082 [DOI] [PubMed] [Google Scholar]
- 8.Mehrparvar AH, Mirmohammadi SJ, Ghoreyshi A, Mollasadeghi A, Loukzadeh Z. High-frequency audiometry: a means for early diagnosis of noise-induced hearing loss. Noise Health. (2011) 13:402–6. doi: 10.4103/1463-1741.90295 [DOI] [PubMed] [Google Scholar]
- 9.U S Government Accountability Office. Commercial Aviation: Pilots and Flight Attendants' Exposure to Noise aboard Aircraft. U.S. GAO (2018). GAO-18-109R. Available online at: https://www.gao.gov/products/gao-18-109r (Accessed July 19, 2026).
- 10.Fehrenbacher K, Apel C, Bartz N, Bertsch D, van der Giet M, van der Giet S, et al. Temporary threshold shift after noise exposure in hypobaric hypoxia at high altitude: results of the ADEMED expedition (2011). Int Arch Occup Environ Health. (2021) 94:1191–9. doi: 10.1007/s00420-021-01715-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Saini S, Sood A, Kotwal N, Kotwal A, Gupta TK. A pilot study comparing hearing thresholds of soldiers at induction and after completion of one year in high altitude area. Med J Armed Forces India. (2021) 77:408–12. doi: 10.1016/j.mjafi.2021.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Attias J, Sohmer H, Gold S, Haran I, Shahar A. Noise and hypoxia induced temporary threshold shifts in rats studied by ABR. Hear Res. (1990) 45:247–52. doi: 10.1016/0378-5955(90)90124-8 [DOI] [PubMed] [Google Scholar]
- 13.Mirza S, Richardson H. Otic barotrauma from air travel. J Laryngol Otol. (2005) 119:366–70. doi: 10.1258/0022215053945723 [DOI] [PubMed] [Google Scholar]
- 14.Stangerup SE, Tjernström Ö, Klokker M, Harcourt J, Stokholm J. Point prevalence of barotitis in children and adults after flight, and effect of autoinflation. Aviation, Space, Environ Med. (1998) 69:45–9. [PubMed] [Google Scholar]
- 15.Miyazawa T, Ueda H, Yanagita N. Eustachian tube function and middle ear barotrauma associated with extremes in atmospheric pressure. Ann Otol Rhinol Laryngol. (1996) 105:887–92. doi: 10.1177/000348949610501109 [DOI] [PubMed] [Google Scholar]
- 16.Bhattacharya S, Singh A, Marzo RR. “Airplane ear”–a neglected yet preventable problem. AIMS Public Health. (2019) 6:320–5. doi: 10.3934/publichealth.2019.3.320 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.O'Neill OJ, Brett K, Frank AJ. Ear Barotrauma. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; (2026). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK499851/ (Accessed July 19, 2026). [Google Scholar]
- 18.International Commission on Radiological Protection. The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP (2007) 37:1–332. doi: 10.1016/j.icrp.2007.10.003 [DOI] [PubMed] [Google Scholar]
- 19.Pukkala E, Aspholm R, Auvinen A, Eliasch H, Gundestrup M, Haldorsen T, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. (2002) 325:567. doi: 10.1136/bmj.325.7364.567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pukkala E, Helminen M, Haldorsen T, Hammar N, Kojo K, Linnersjö A, et al. Cancer incidence among Nordic airline cabin crew. Int J Cancer. (2012) 131:2886–97. doi: 10.1002/ijc.27551 [DOI] [PubMed] [Google Scholar]
- 21.Langner I, Blettner M, Gundestrup M, Storm H, Aspholm R, Auvinen A, et al. Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys. (2004) 42:247–56. doi: 10.1007/s00411-003-0214-7 [DOI] [PubMed] [Google Scholar]
- 22.Hammer GP, Auvinen A, De Stavola BL, Grajewski B, Gundestrup M, Haldorsen T, et al. Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med. (2014) 71:313–22. doi: 10.1136/oemed-2013-101395 [DOI] [PubMed] [Google Scholar]
- 23.Toprani SM, Scheibler C, Mordukhovich I, McNeely E, Nagel ZD. Cosmic ionizing radiation: a DNA-damaging agent that may underly excess cancer in flight crews. Int J Mol Sci. (2024) 25:7670. doi: 10.3390/ijms25147670 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Copeland K. CARI-7A: development and validation. Radiat Prot Dosimetry. (2017) 175:419–31. doi: 10.1093/rpd/ncw369 [DOI] [PubMed] [Google Scholar]
- 25.Mertens CJ, Meier MM, Brown S, Norman RB, Xu X. NAIRAS aircraft radiation model development, dose climatology, and initial validation. Space Weather. (2013) 11:603–35. doi: 10.1002/swe.20100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bottollier-Depois JF, Chau Q, Bouisset P, Kerlau G, Plawinski L, Lebaron-Jacobs L. Assessing exposure to cosmic radiation during long-haul flights. Radiat Res. (2000) 153:526–32. doi: 10.1667/0033-7587(2000)153[0526:AETCRD]2.0.CO;2 [DOI] [PubMed] [Google Scholar]
- 27.Lee J, Nam UW, Pyo J, Kim S, Kwon YJ, Lee J, et al. Short-term variation of cosmic radiation measured by aircraft under constant flight conditions. Space Weather. (2015) 13:797–806. doi: 10.1002/2015SW001288 [DOI] [Google Scholar]
- 28.Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys. (2010) 76:S50–7. doi: 10.1016/j.ijrobp.2009.04.096 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Theunissen EAR, Bosma SCJ, Zuur CL, Spijker R, van der Baan S, Dreschler WA, et al. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature. Head Neck. (2015) 37:281–92. doi: 10.1002/hed.23551 [DOI] [PubMed] [Google Scholar]
- 30.Liu Z, Luo Y, Guo R, Yang B, Shi L, Sun J, et al. Head and neck radiotherapy causes significant disruptions of cochlear ribbon synapses and consequent sensorineural hearing loss. Radiother Oncol. (2022) 173:207–14. doi: 10.1016/j.radonc.2022.05.023 [DOI] [PubMed] [Google Scholar]
- 31.Noreña AJ, Eggermont JJ. Enriched acoustic environment after noise trauma reduces hearing loss and prevents cortical map reorganization. J Neurosci. (2005) 25:699–705. doi: 10.1523/JNEUROSCI.2226-04.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Noreña AJ, Eggermont JJ. Enriched acoustic environment after noise trauma abolishes neural signs of tinnitus. Neuroreport. (2006) 17:559–63. doi: 10.1097/00001756-200604240-00001 [DOI] [PubMed] [Google Scholar]
- 33.Recanzone GH, Schreiner CE, Merzenich MM. Plasticity in the frequency representation of primary auditory cortex following discrimination training in adult owl monkeys. J Neurosci. (1993) 13:87–103. doi: 10.1523/JNEUROSCI.13-01-00087.1993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Eggermont JJ. Acquired hearing loss and brain plasticity. Hear Res. (2017) 343:176–90. doi: 10.1016/j.heares.2016.05.008 [DOI] [PubMed] [Google Scholar]
- 35.Kwak E, Kwak S. Threshold sound conditioning in the treatment of sensorineural hearing loss. Laryngosc Investig Otolaryngol. (2020) 5:438–44. doi: 10.1002/lio2.399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cho S, Kwak E, Kwak S, Lopez J. Randomized controlled trial evaluating threshold sound conditioning in the treatment of sensorineural hearing loss (S26.006). Neurology. (2015) 84:S26.006. doi: 10.1212/WNL.84.14_supplement.S26.006 [DOI] [Google Scholar]
- 37.Kwak E, Kwak S. Erratum: threshold sound conditioning in the treatment of sensorineural hearing loss (vol 5, pg 438, 2020). Laryngosc Investig Otolaryngol. (2021) 6:1489. doi: 10.1002/lio2.680 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lindborg L, Bartlett D, Beck P, McAulay I, Schnuer K, Schraube H, et al. Cosmic radiation exposure of aircraft crew: compilation of measured and calculated data. Radiat Prot Dosimetry. (2004) 110:417–22. doi: 10.1093/rpd/nch232 [DOI] [PubMed] [Google Scholar]
- 39.Meier MM, Trompier F, Ambrozova I, Kubancak J, Matthiä D, Ploc O, et al. CONCORD: comparison of cosmic radiation detectors in the radiation field at aviation altitudes. J Space Weather Space Clim. (2016) 6:A24. doi: 10.1051/swsc/2016017 [DOI] [Google Scholar]
- 40.Breiman L. Random forests. Mach Learn. (2001) 45:5–32. doi: 10.1023/A:1010933404324 [DOI] [Google Scholar]
- 41.Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. (2001) 29:1189–232. doi: 10.1214/aos/1013203451 [DOI] [Google Scholar]
- 42.Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. (2011) 12:2825–30. [Google Scholar]
- 43.Matthiä D, Meier MM, Reitz G. Numerical calculation of the radiation exposure from galactic cosmic rays at aviation altitudes with the PANDOCA core model. Space Weather. (2014) 12:161–71. doi: 10.1002/2013SW001022 [DOI] [Google Scholar]
- 44.Bartlett DT. Radiation protection aspects of the cosmic radiation exposure of aircraft crew. Radiat Prot Dosimetry. (2004) 109:349–55. doi: 10.1093/rpd/nch311 [DOI] [PubMed] [Google Scholar]
- 45.Simonsen LC, Slaba TC, Guida P, Rusek A. NASA's first ground-based galactic cosmic ray simulator: enabling a new era in space radiobiology research. PLoS Biol. (2020) 18:e3000669. doi: 10.1371/journal.pbio.3000669 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cucinotta FA, Alp M, Sulzman FM, Wang M. Space radiation risks to the central nervous system. Life Sci Space Res. (2014) 2:54–69. doi: 10.1016/j.lssr.2014.06.003 [DOI] [Google Scholar]
- 47.Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. (2007) 67:469–79. doi: 10.1016/j.ijrobp.2006.09.017 [DOI] [PubMed] [Google Scholar]
- 48.Mujica-Mota MA, Lehnert S, Devic S, Gasbarrino K, Daniel SJ. Mechanisms of radiation-induced sensorineural hearing loss and radioprotection. Hear Res. (2014) 312:60–68. doi: 10.1016/j.heares.2014.03.003 [DOI] [PubMed] [Google Scholar]
- 49.Shi W, Hou X, Bao X, Hou W, Jiang X, Ma L, et al. Mechanism and protection of radiotherapy-induced sensorineural hearing loss for head and neck cancer. Biomed Res Int. (2021) 2021:3548706. doi: 10.1155/2021/3548706 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kujawa SG, Liberman MC. Adding insult to injury: cochlear nerve degeneration after “temporary” noise-induced hearing loss. J Neurosci. (2009) 29:14077–85. doi: 10.1523/JNEUROSCI.2845-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Liberman MC, Epstein MJ, Cleveland SS, Wang H, Maison SF. Toward a differential diagnosis of hidden hearing loss in humans. PLoS ONE. (2016) 11:e0162726. doi: 10.1371/journal.pone.0162726 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Brozoski TJ, Spires TJD, Bauer CA. Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol. (2007) 8:105–18. doi: 10.1007/s10162-006-0067-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Tyler RS, Coelho C, Tao P, Ji H, Noble W, Gehringer A, et al. Identifying tinnitus subgroups with cluster analysis. Am J Audiol. (2008) 17:S176–84. doi: 10.1044/1059-0889(2008/07-0044) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kwak S. Method and Device for Objective Automated Audiometry. US Patent No 8,177,727 (Earlogic Korea, Inc. and Sangyeop Kwak), granted 15 May 2012 (2012). [Google Scholar]
- 55.Lee D, Kwak S, Jang S. Method and Apparatus for Hearing Improvement Based on Cochlear Model. US Patent No 11,070,924 (GoldenEar Company, Inc., Valencia, CA), granted 20 July 2021 (2021). [Google Scholar]
- 56.Kwak S, Lee D, Jang S, Kim S, Kim S, Doo W, et al. Stochastic modeling of tinnitus loudness. bioRxiv. (2023). doi: 10.1101/2023.02.09.527783 [DOI] [Google Scholar]
- 57.Verhulst S, Altoe A, Vasilkov V. Computational modeling of the human auditory periphery: auditory-nerve responses, evoked potentials and hearing loss. Hear Res. (2018) 360:55–75. doi: 10.1016/j.heares.2017.12.018 [DOI] [PubMed] [Google Scholar]
- 58.Zilany MSA, Bruce IC, Carney LH. Updated parameters and expanded simulation options for a model of the auditory periphery. J Acoust Soc Am. (2014) 135:283–6. doi: 10.1121/1.4837815 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Carney LH. A model for the responses of low-frequency auditory-nerve fibers in cat. J Acoust Soc Am. (1993) 93:401–17. doi: 10.1121/1.405620 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
